期刊文献+

抗转铁蛋白受体单链抗体的可溶性表达及其对脑的靶向性研究 被引量:4

Soluble Expression and Target Study to Brain of Anti- TfR ScFv
下载PDF
导出
摘要 分段合成大鼠抗转铁蛋白受体单链抗体基因 (ox2 6_scFv) ,经三轮PCR拼接成 794bp的完整片段。测序后构建pTIG_Trx ox2 6_scFv表达载体 ,在大肠杆菌BL2 1(DE3)中获得了可溶性表达 ,经Ni_NTA金属鏊合层析柱纯化 ,在2 9kD处可见单一条带。大鼠GH3细胞免疫组化显示 ,该单链抗体能识别并与转铁蛋白受体结合。将单链抗体尾静脉注射大鼠 ,于鼠脑组织切片上可见阳性染色 ,尤其是脑血管处着色明显 ,说明该单链抗体对脑血管具有较好的靶向作用 ,并在受体的介导下通过了血脑屏障。 The single-chain antibody gene(ox26-scFv) to transferrin receptor(TfR) was synthesized and amplified by three-step PCR. After sequencing, the gene was cloned into prokaryotic expression vector pTIG-Trx which carried thioredoxin (Trx) gene and a C-terminal His.tag. The Ox26-scFv proteins achieved 31% yields of total bacteria proteins at 20℃, after 0.02mM IPTG induction using the strain E.coli BL21(DE3). The soluble scFv proteins in cytoplasm suspension were about 35% and the inclusion bodies were about 65%. The soluble products were purified by immobilized metal chelation affinity chromatography(Ni-NTA), a single band with molecular weight 29 kD appeared on SDS-PAGE gel. Rat GH3 cell immunocytochemistry staining showed that Ox26-scFv protein could recognize and bind to transferrin receptor. Injected SD rats with Ox26-scFv proteins by tail veins, the antibodies were detected from brain tissues specially on the brain capillaries 4 h later which indicate that Ox26-scFv proteins have a good target function to brain capillaries and can permeate the blood-brain barrier mediated by the transferrin receptors.
出处 《生物工程学报》 CAS CSCD 北大核心 2004年第3期342-347,共6页 Chinese Journal of Biotechnology
基金 国家自然科学基金项目资助 (No .3 0 3 0 0 10 2 北京市自然科学基金资助 (No .5 0 42 0 2 2 )~~
关键词 转铁蛋白受体 单链抗体 血脑屏障 可溶性表达 药物转运 transferrin receptor(TfR), single-chain Fv(scFv), blood-brain barrier(BBB), soluble expression, drug delivery
  • 相关文献

参考文献9

  • 1Pardridge WM. Recent developments in peptide drug delivery to the brain. Pharm Toxi, 1992,71:3- 10
  • 2Friden PM. Receptor-mediated transport of therapeutics across the blood-brain barrier. Neurosurgery, 1994,35: 294 - 298
  • 3Friden PM, Walus LR, Watson P. Blood-brain barrier penetration and in vivo activity of an NGF conjugate. Science, 1993, 259:373 -377
  • 4Coloma MJ, Lee HJ, Kurihara A et al. Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor. Pharm Res, 2000, 17(3):266 - 274
  • 5Zhang Y, Pardridge WM. Conjugation of brain-derived neurotrophic factor to a blood-brain barrier drug targeting system enables neuroprotection in regional brain ischemia following intravenous injection of the neurotrophin. Brain Res, 2001, 889:49 - 56
  • 6Li JY, Sugimura K, Boado RJ. Genetically engineered brain drug delivery vectors: cloning, expression and in vivo application of an anti-transferrin receptor single chain antibody-streptavidin fusion gene and protein. Protein Eng, 1999, 12(9) :787 - 796
  • 7Deiel IR, Stearne PR, Grego B. The receptor for transferring on murine myeloma cells: one-step purification based on its physiology, and partial amino acid sequence. J Immunol, 1984, 133(6):3220-3223
  • 8Lee HJ, Engelhardt B, Lesley J. Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse.J Pharmacol Exp Ther, 2000, 292(3): 1048- 1052
  • 9Zhang Z(张众),Huang HL(黄华樑).Escherichia coli disulfideforming related protein: structures, functions and their application in gene engineering for expressing heterologous proteins in Escherichia coli.Chinese Journal of Biotechnology(生物工程学报),2002,

同被引文献26

  • 1杨远,贾文祥,祁欣,曾蔚,杨发龙,谢轶,杨维青,张再容,周绍兵,李孝红.可生物降解材料作为基因载体的研究[J].生物医学工程学杂志,2006,23(3):573-577. 被引量:4
  • 2Pardridge WM.Recent developments in peptide drug delivery to the brain[J]. Pharm Toxi, 1992,71:3
  • 3Friden PM. Receptor-mediated transport of therapeutics across the blood-brain barrier[J]. Neurosurgery, 1994,35:294
  • 4Friden PM, Walus LR, Watson P. Blood-brain barrier penetration and in vivo activity of an NGF conjugate[J]. Science, 1993,259:373
  • 5Coloma MJ,Lee HJ, Kurihara A, et al. Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor[J]. Pharm Res, 2000,17(3):266
  • 6Zhang Y, Pardridge WM. Conjugation of brain-derived neurotrophic factor to a blood-brain barrier drug targeting system enables neuroprotection in regional brain ischemia following intravenous injection of the neurotrophin[J]. Brain Res, 2001,889:49
  • 7Zhang Y,Pardridge WM,Conjugation of brain-derived neurotrophic factor to a blood-brain barrier drug ischemia following intravenous injection of the neurotrophin,Brain Res.2001.889:49-56.
  • 8Turkewitz AP,Amatruda JF,Borhani D et al.A high yield purification of the human transferrin receptor and properities of its major extracellular fragment,J Bio Chem,1988,263(17):8318-8325.
  • 9Griffiths AD,Willianms SC,Hartley O et al.Isolation of high affinity human antibodies directly from large synthetic repertoire.EMBO J,1994,13:3245-3260.
  • 10Triguero D,Buciak J,Pardridge WM,Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins.J Neurochem,1990,54(6):1882-1887.

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部